These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 20674181

  • 1. Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm--A case-control study of coronary artery disease.
    Szymanowski A, Nijm J, Kristenson M, Jonasson L.
    Psychoneuroendocrinology; 2011 Jan; 36(1):139-43. PubMed ID: 20674181
    [Abstract] [Full Text] [Related]

  • 2. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S, Kim JO, Methe H.
    Am J Cardiol; 2010 Feb 15; 105(4):429-34. PubMed ID: 20152234
    [Abstract] [Full Text] [Related]

  • 3. Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity.
    Nijm J, Kristenson M, Olsson AG, Jonasson L.
    J Intern Med; 2007 Sep 15; 262(3):375-84. PubMed ID: 17697159
    [Abstract] [Full Text] [Related]

  • 4. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
    Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I.
    Clin Chim Acta; 2012 Jan 18; 413(1-2):113-20. PubMed ID: 21963461
    [Abstract] [Full Text] [Related]

  • 5. Enhanced neutrophil expression of annexin-1 in coronary artery disease.
    Särndahl E, Bergström I, Nijm J, Forslund T, Perretti M, Jonasson L.
    Metabolism; 2010 Mar 18; 59(3):433-40. PubMed ID: 19850308
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S, Melandri G, Hanemaaijer R, Cervi V, Tomasi L, Altimari A, Van Lent N, Tricoci P, Bacchi L, Branzi A.
    Transl Res; 2007 Mar 18; 149(3):137-44. PubMed ID: 17320799
    [Abstract] [Full Text] [Related]

  • 7. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM, Jacob-Ferreira AL, Gomes VA, Casella-Filho A, Chagas AC, Marcaccini AM, Gerlach RF, Tanus-Santos JE.
    Clin Chim Acta; 2009 May 18; 403(1-2):173-7. PubMed ID: 19254704
    [Abstract] [Full Text] [Related]

  • 8. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
    Jguirim-Souissi I, Jelassi A, Addad F, Hassine M, Najah M, Ben Hamda K, Maatouk F, Ben Farhat M, Bouslema A, Rouis M, Slimane MN.
    Am J Cardiol; 2007 Jul 01; 100(1):23-7. PubMed ID: 17599435
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Tayebjee MH, Nadar S, Blann AD, Gareth Beevers D, MacFadyen RJ, Lip GY.
    Am J Hypertens; 2004 Sep 01; 17(9):764-9. PubMed ID: 15363817
    [Abstract] [Full Text] [Related]

  • 10. Evidence for altered hypothalamus-pituitary-adrenal axis functioning in systemic hypertension: blunted cortisol response to awakening and lower negative feedback sensitivity.
    Wirtz PH, von Känel R, Emini L, Ruedisueli K, Groessbauer S, Maercker A, Ehlert U.
    Psychoneuroendocrinology; 2007 Jun 01; 32(5):430-6. PubMed ID: 17433557
    [Abstract] [Full Text] [Related]

  • 11. Acute HPA axis responses, heart rate, and mood changes to psychosocial stress (TSST) in humans at different times of day.
    Kudielka BM, Schommer NC, Hellhammer DH, Kirschbaum C.
    Psychoneuroendocrinology; 2004 Sep 01; 29(8):983-92. PubMed ID: 15219648
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inflammation and cortisol response in coronary artery disease.
    Nijm J, Jonasson L.
    Ann Med; 2009 Sep 01; 41(3):224-33. PubMed ID: 18979272
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.
    Kern S, Schultheiss T, Schneider H, Schrempf W, Reichmann H, Ziemssen T.
    Psychoneuroendocrinology; 2011 Nov 01; 36(10):1505-12. PubMed ID: 21621332
    [Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
    Derosa G, D'Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, Montagna L, Gravina A, Ferrari I, Galli S, Paniga S, Tinelli C, Cicero AF.
    Endothelium; 2006 Nov 01; 13(3):227-31. PubMed ID: 16840178
    [Abstract] [Full Text] [Related]

  • 18. Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: the SMART-Medea study.
    Knoops AJ, Gerritsen L, van der Graaf Y, Mali WP, Geerlings MI.
    Biol Psychiatry; 2010 Jun 15; 67(12):1191-8. PubMed ID: 20299006
    [Abstract] [Full Text] [Related]

  • 19. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW.
    Eur J Clin Invest; 2005 Sep 15; 35(9):537-45. PubMed ID: 16128859
    [Abstract] [Full Text] [Related]

  • 20. Exhaustion measured by the SF-36 vitality scale is associated with a flattened diurnal cortisol profile.
    Lindeberg SI, Eek F, Lindbladh E, Ostergren PO, Hansen AM, Karlson B.
    Psychoneuroendocrinology; 2008 May 15; 33(4):471-7. PubMed ID: 18295411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.